Living with IBM: A Personal Journey

The provided texts offer information on experimental or alternative health treatments, juxtaposed with a government resource for established supplements. One article focuses heavily on the peptide BPC-157, detailing its potential benefits for healing, muscle recovery, and anti-aging, while acknowledging its lack of FDA approval and discussing dosage and side effects. Another source is a PubMed review on Low-Dose Naltrexone (LDN), presenting it as a promising, safe, yet limited therapy for various rheumatic diseases like fibromyalgia. In contrast, the MedlinePlus source provides an alphabetical index of common, federally referenced herbs and supplements, highlighting its function as an official government resource for known dietary products. Finally, a personal account describes a company founder's journey with Inclusion Body Myositis (IBM) and her dedication to sharing her own experiences with supplements and prescriptions to help others navigate their diagnoses.

Alicia D. Polak
Chief Enabled Officer
Email: alicia@thedisabledcompany.com
Instagram: @aliciathedisabledcompany.com
Website: www.thedisabledcompany.com